|
|
Article: ChrysCap to buy 12 percent in Intas Pharma.(Company Profile)
- Article from:
- Economic Times (New Delhi, India)
- Article date:
- December 13, 2005
CopyrightCOPYRIGHT 2005 The Economic Times. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Dec. 13--NEW DELHI -- Private equity major, ChrysCapital is close to acquiring a 12.4 percent stake in Intas Pharmaceuticals from Unit Trust of India in a deal worth Rs 53 crore. The acquisition is being done through Mozart, a Mauritius-based subsidiary of ChrysCapital III, Mauritius.
The government has approved its plea to acquire over 5.8 lakh equity shares of the Ahmedabad-based pharma major constituting 12.47 percent of its existing paid-up capital. The purchase is being done at the rate of a little over Rs 912 per share.
Intas Pharma is a leading player in the high growth theurapeutic areas of neurology, psychiatry, cardiology, diabetology, ...